ReLive

ReLive is a leader in tissue engineering and regenerative medicine, focusing on the repair and reconstruction of tissues and organs. Since its establishment, ReLive has built R&D, clinical, and CMC teams in Boston, USA, as well as in Nanjing and Beijing, China. It has also introduced a strategic and scientific advisory board composed of top global scholars, clinical experts, and industry leaders in the field of tissue engineering and regenerative medicine. At the product development level, ReLive is not limited to the orthopedic field but will continue to collaborate with international institutions such as Harvard University and MIT, as well as industry leaders, to expand innovative product lines and broaden application areas. The company will utilize cutting-edge cell and gene therapy technologies and the deep development and organic integration of novel biomaterial scaffolds. Targeting fields including orthopedic sports medicine (such as articular cartilage, osteochondral, and meniscus repair) and plastic and aesthetic surgery (such as ear reconstruction), ReLive is committed to becoming an international leader in the field of tissue engineering and regenerative medicine.